Education
About Us
Working with TipRanks
Follow Us
Joseph M Miller Insider Profile
4 Followers
Joseph M Miller, Director at Avalo Therapeutics, holds 577.36K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 40.58K shares in Avalo Therapeutics (Ticker: AVTX).
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-0.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joseph M Miller holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 06, 2023 - Mar 06, 2024
Return:+39.80%
The most profitable trade made by Joseph M Miller
Joseph M Miller's Trading History
Avalo Therapeutics
Jun 11, 2020
Director
Uninformative Sell
14.40K
$314.92K
Aurinia Pharmaceuticals
Mar 04, 2025
CFO
Uninformative Buy
―
$4.71M
List of latest transactions for each holding click on a transaction to see Joseph M Miller's performance on stock
You May Also Like
Joseph M Miller insider profile FAQ
What is the percentage of profitable transactions made by Joseph M Miller?
The percentage of profitable transactions made by Joseph M Miller is 40%.
What is the average return per transaction made by Joseph M Miller?
The average return per transaction made by Joseph M Miller is -0.20%.
What stocks does Joseph M Miller hold?
Joseph M Miller holds: AVTX, AUPH stocks.
What was Joseph M Miller’s latest transaction?
Joseph M Miller latest transaction was an Uninformative Buy of ―.
What was Joseph M Miller's most profitable transaction?
Joseph M Miller’s most profitable transaction was an Informative Sell of AUPH stock on March 6, 2023. The return on the trade was 39.80%.
What is Joseph M Miller's role in Avalo Therapeutics?
Joseph M Miller's role in Avalo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.